WuXi XDC Cayman Inc

HKSE:02268 (China)  
HK$ 18.98 (-1.86%) Apr 24
60.06
P/B:
3.81
Market Cap:
HK$ 22.73B ($ 2.90B)
Enterprise V:
HK$ 18.79B ($ 2.40B)
Volume:
1.99M
Avg Vol (2M):
3.20M
Also Trade In:
Volume:
1.99M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for WuXi XDC Cayman Inc ( HKSE:02268 ) from 2023 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. WuXi XDC Cayman stock (HKSE:02268) PE ratio as of Apr 24 2024 is 60.06. More Details

WuXi XDC Cayman Inc (HKSE:02268) PE Ratio (TTM) Chart

To

WuXi XDC Cayman Inc (HKSE:02268) PE Ratio (TTM) Historical Data

Total 107
  • 1
  • 2
WuXi XDC Cayman PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-24 113.0 2024-02-19 84.2
2024-04-24 113.0 2024-02-16 86.4
2024-04-23 115.1 2024-02-15 77.3
2024-04-22 111.5 2024-02-14 79.6
2024-04-19 103.3 2024-02-09 87.1
2024-04-18 105.4 2024-02-08 88.1
2024-04-17 104.2 2024-02-07 107.0
2024-04-16 99.8 2024-02-06 103.3
2024-04-15 109.2 2024-02-05 99.2
2024-04-12 113.1 2024-02-02 105.8
2024-04-11 117.3 2024-02-01 127.1
2024-04-10 118.3 2024-01-31 118.5
2024-04-09 117.7 2024-01-30 130.4
2024-04-08 111.5 2024-01-29 146.4
2024-04-05 107.7 2024-01-26 150.0
2024-04-03 111.0 2024-01-25 187.5
2024-04-02 108.0 2024-01-24 189.9
2024-03-28 108.9 2024-01-23 184.5
2024-03-27 101.4 2024-01-22 179.2
2024-03-26 98.9 2024-01-19 182.7
2024-03-25 107.1 2024-01-18 190.2
2024-03-22 106.5 2024-01-17 179.8
2024-03-21 107.0 2024-01-16 189.6
2024-03-20 98.5 2024-01-15 188.4
2024-03-19 99.6 2024-01-12 179.8
2024-03-18 99.6 2024-01-11 194.6
2024-03-15 93.0 2024-01-10 177.7
2024-03-14 96.4 2024-01-09 171.4
2024-03-13 117.6 2024-01-08 172.3
2024-03-12 121.4 2024-01-05 184.5
2024-03-11 120.2 2024-01-04 192.0
2024-03-08 124.7 2024-01-03 189.3
2024-03-07 124.4 2024-01-02 187.5
2024-03-06 138.1 2023-12-29 190.5
2024-03-05 133.0 2023-12-28 187.5
2024-03-04 138.7 2023-12-27 101.3
2024-03-01 111.1 2023-12-22 105.7
2024-02-29 108.3 2023-12-21 100.8
2024-02-28 108.5 2023-12-20 103.2
2024-02-27 109.5 2023-12-19 101.9
2024-02-26 113.7 2023-12-18 98.6
2024-02-23 105.8 2023-12-15 95.9
2024-02-22 105.6 2023-12-14 94.5
2024-02-21 110.4 2023-12-13 90.3
2024-02-20 98.8 2023-12-12 92.1

WuXi XDC Cayman Inc (HKSE:02268) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

WuXi XDC Cayman Inc

ISIN : KYG9808A1058
Compare
Compare
Traded in other countries / regions
02268.Hong KongL74.Germany
IPO Date
2023-11-17
Description
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.